E-DRUG: Utrecht 'Pharmaceutical Policy Analysis' July course - update
------------------------------------------------------------------
[To respond DO NOT CLICK REPLY. Respond directly to Pieter Stolk <p.stolk@uu.nl> ]
Utrecht Summer Course in 'Pharmaceutical Policy Analysis' (2-6 July 2007) - update about contents & faculty
Dear colleagues,
Last month (e-drug 8 March 2007), I have sent you a message about two Summer Courses in 'Pharmacoepidemiology & Drug Safety' and 'Pharmaceutical Policy Analysis' that will be hosted by Utrecht University (The Netherlands) this summer. With this message I would like to update you on the contents and the faculty of the Pharmaceutical Policy Analysis Summer Course that will be held from 2-6 July 2007 in Utrecht, The Netherlands and which is organised in collaboration with the World Health Organization. In the last few weeks, we have been able to confirm the majority of the course faculty and the course topics. Below you will find more information about this.
SUMMER COURSE IN PHARMACEUTICAL POLICY ANALYSIS (2-6 JULY 2007) - UPDATE
BACKGROUND OF THE COURSE
Medicines are among the most regulated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. Priority Medicines and Orphan Drugs are examples of concepts that aim to energise new 'social contracts' between society and drug innovators.
When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, pharmacists, insurers, pharmaceutical companies and governments. Furthermore, from a global perspective, the reality is that two billion people do not have access to essential medicines. The inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place.
This course will cover these issues from a scientific, regulatory, public health and international policy perspective. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.
COURSE LEADERS
Prof Dr Bert Leufkens (Utrecht University), Dr Richard Laing (World Health Organization) and Pieter Stolk (Utrecht University).
TENTATIVE COURSE SCHEDULE
The tentative course schedule will include the following topics+confirmed faculty:
- Introduction to the course and methods in pharmaceutical policy analysis
Prof Bert Leufkens (Utrecht University, The Netherlands)
- The pharmaceutical policy analysis landscape - current issues
Dr Kees de Joncheere (WHO)
- Building clinical evidence for policymaking
Prof Ton de Boer (Utrecht University, The Netherlands)
- Regulating sustainable delivery systems for Medicines
Prof Marie-Helene Schutjens (Utrecht University, The Netherlands)
- Product 'Life Cycles' and drug regulation
Prof Toine Pieters (Free University of Amsterdam, The Netherlands)
- Access, affordability and medicine prices
Dr Richard Laing (WHO) + faculty from Health Action International
- Ethics, human rights and equity
Dr Hans Hogerzeil (WHO)
- Prescribing of medicines, drug promotion, and evidence-based medicine
Dr Barbara Mintzes (University of British Columbia, Canada)
- Drug usage, adherence to therapy and patient needs
Dr Rob Heerdink (Utrecht University, The Netherlands) + Dr Richard Laing (WHO)
- 'Priority Medicines' as a pharmaceutical policy analysis tool
Dr Richard Laing (WHO) + Prof Bert Leufkens (Utrecht University, The Netherlands)
- Towards an ideal model for policy and innovation
Prof Daan Crommelin (Dutch Top Institute Pharma/Utrecht University, The Netherlands) + Prof Donald Light (Netherlands Institute for Advanced Study/University of Medicine and Dentistry of New Jersey, USA)
TARGET GROUP
(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge of public health/medicine or pharmacy who have an interest in the policy aspects of pharmaceuticals.
If you are interested in registering for this course, the deadline for registration is 31 May 2007. The fee for the course is 750 EUR. The Pharmaceutical Policy Analysis Summer Course can be combined with the Summer Course in Pharmacoepidemiology & Drug Safety (25-29 June, see: http://www.utrechtsummerschool.nl/index.php?page=courses&code=M8) for a 'combination fee' of 1250 EUR. For more information about the application procedure, and all other courses in the Utrecht Summer School 2007, please visit: http://www.utrechtsummerschool.nl/ or contact Pieter Stolk (p.stolk@uu.nl).
If you have any questions about the Pharmaceutical Policy Analysis Summer Course, please do not hesitate to contact me.
Best regards,
Pieter Stolk
Utrecht University, Faculty of Science
Utrecht Institute for Pharmaceutical Sciences
Division of Pharmacoepidemiology & Pharmacotherapy
PO Box 80 082, 3508 TB Utrecht, The Netherlands
Tel +31 30 253 6719
Fax +31 30 253 9166
E-mail P.Stolk@uu.nl